Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

08 Nov, EOD - Indian

SENSEX 79486.32 (-0.07)

Nifty 50 24148.2 (-0.21)

Nifty Bank 51561.2 (-0.68)

Nifty IT 42050.15 (0.71)

Nifty Midcap 100 56352 (-1.33)

Nifty Next 50 69774.2 (-1.23)

Nifty Pharma 22542.25 (0.07)

Nifty Smallcap 100 18445.6 (-1.70)

08 Nov, EOD - Global

NIKKEI 225 39500.37 (0.30)

HANG SENG 20728.19 (-1.07)

S&P 6014.5 (-0.02)

Cancel

BSE Code : 500124 | NSE Symbol : DRREDDY | ISIN : INE089A01031 | Industry : Pharmaceuticals |

(06-Nov-24 13:05) Dr Reddys Laboratories Ltd spurts 2.25%
(05-Nov-24 17:35) Dr Reddy's Q2 PAT slides 15% YoY to Rs 1,255 crore
(05-Nov-24 17:09) Dr Reddy's Laboratories consolidated net profit declines 15.28% in the September 2024 quarter
(08-Oct-24 18:16) Aurigene Oncology receives nod for Phase 2 clinical trial for Ribrecabtagene autoleucel
(05-Oct-24 11:37) Dr Reddys announces incorporation of new step-down subsidiary in Denmark
(30-Sep-24 17:31) Dr Reddys acquires Haleon plc brands in NRT category
(23-Sep-24 10:11) Dr Reddys Laboratories schedules board meeting
(19-Sep-24 13:35) Dr Reddys Laboratories Ltd down for fifth straight session
(06-Sep-24 13:35) Dr Reddys Laboratories Ltd eases for fifth straight session
(06-Sep-24 12:15) Dr Reddy’s Labs Andhra Pradesh facility gets EIR from USFDA

1 2 3 4 5 6 7 8 9 10

Dr Reddys Laboratories Ltd